A new study suggests that your waistline may offer more insight into your brain health than the number on the scale—particularly for older men. When assessing dementia risk, where body fat is stored seems to matter more than how much there is. New research led by Monash University seeks to clarify conflicting findings from earlier […]
Not All Types of Body Fat Carry the Same Risk for Developing Dementia Read More »
If you’re hoping to fit in more exercise tomorrow, going to bed earlier tonight might make a difference, according to a new study that explored how bedtime habits relate to physical activity the next day. Conducted by researchers at Monash University in Australia, the study doesn’t claim that earlier bedtimes directly cause increased exercise, but it
A Simple Shift in Your Evening Habits Might Make It Easier To Exercise Regularly Read More »
A new drug developed by California-based pharmaceutical company Amgen has shown strong potential as an effective obesity treatment. In a completed phase II trial, participants receiving a once-monthly injection of the drug—called MariTide—lost up to 16% of their body weight within a year. That level of weight loss is similar to the average results seen
Monthly Injection Reduces Body Weight by 16% in Landmark Obesity Study Read More »
A new immune-modulating therapy has demonstrated encouraging outcomes in treating moderate to severe eczema, offering rapid itch relief and clearer skin for many participants in a clinical trial—without the typical side effects linked to existing treatments. For some individuals, managing atopic dermatitis—the most prevalent and widely recognized form of eczema—can be difficult, particularly when it
New Eczema Therapy Shows Promising Relief In Phase 2 Clinical Trials Read More »
France’s national blood agency has confirmed that a woman from Guadeloupe, a French Caribbean island, carries the newly identified blood type ‘Gwada negative’—the only known case in the world. The French Blood Establishment (EFS) revealed on Friday that this discovery comes 15 years after scientists first received her blood sample during standard pre-surgery testing. “We’ve
Researchers Discover New Blood Type, The Rarest Ever Found Read More »
If you’re dealing with an upset stomach, vomiting, and diarrhoea, it’s common to chalk it up to a “tummy bug” or something you ate. But what’s really behind it—gastro or food poisoning? And is there even a difference? What Exactly Is Gastroenteritis? Gastroenteritis—often called “gastro” is an infection of the gut triggered by a virus,
Gastro or Food Poisoning? A Quick Guide to What’s Upsetting Your Stomach Read More »
Detecting Parkinson’s Disease early is crucial for slowing its progression and enhancing a patient’s quality of life. A new test, using only a small earwax sample, aims to do just that. Parkinson’s affects around 10 million people worldwide, yet doctors still lack a definitive method to diagnose it in its early stages. Current approaches rely
Doctors Detect Indicators Of Parkinson’s Disease By Inspecting The Inner Ear Read More »
Many creatures on Earth are known to emit visible light, but humans typically aren’t thought to be among them. However, that assumption might not be entirely accurate. As far back as 1923, research has shown that humans give off faint light—luminescence at frequencies that, while technically visible, are far too dim for the human eye
Your Brain Gives Off a Hidden Glow and Scientists Are Working to Decode It Read More »
The U.S. Food and Drug Administration (FDA) has approved Gilead Sciences’ twice-a-year injectable medication for HIV prevention, a development the company has called a major leap forward in the battle against the virus. While pre-exposure prophylaxis (PrEP) has been available for over a decade, most options require daily oral dosing, limiting their overall impact on
Major Milestone: FDA Greenlights Biannual HIV Prevention Injection Read More »
A breakthrough cancer therapy aimed at treating so-called “undruggable” cancers is scheduled to enter human trials in 2025. This innovative treatment targets tumors driven by the MYC oncogene and its associated protein, with the goal of slowing tumor growth and improving treatment outcomes. The Role of the MYC Oncogene in Cancer Progression The MYC gene
Groundbreaking Trial for “Undruggable” Cancer Target Set to Begin Read More »